MAX - SHOCK Clinical Trial

A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 376 participants.

Also called NCT06556667

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; single masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 376 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT06556667
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Canada (from the registry)
Registry status
  • Recruiting (from the registry)

Technical summary

Registry record NCT06556667. Randomized; single masking; primary purpose treatment. Start 2025-03-31 (actual); primary completion 2027-09-01 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
MAX - SHOCK Clinical Trial
Acronym
MAX-SHOCK
Condition
Cardioversion
Intervention (Device)
biphasic defibrillator with maximum energy of 200J (® Zoll)
Intervention (Device)
biphasic defibrillator with maximum energy of 360J (® Physio-Control)
Lead sponsor
Ottawa Heart Institute Research Corporation (class: other)

Record details

Record id
cardio:ct-nct06556667
Content hash
99f34167040d77a9158ee622d3966a3d53e1d76de429d4a2468cd52e13464a96